pathologic – Page 3 – Communicable Diseases Research

Three-Week Old Pigs Are Not Susceptible to Productive Infection with SARS-COV-2

Article

Published on 2022-02-102022-10-29
Journal: Microorganisms [Category] COVID-19,

Lymphadenopathy post‐COVID‐19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review

Review

Published on 2022-02-072022-10-04
Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 치료기술,

[키워드] approved AstraZeneca AztraZeneca biopsies biopsy caused changes in coronavirus Coronavirus disease 2019 COVID‐19 COVID‐19 COVID‐19 vacccine database death drug Efficacy and safety FDG fluorodeoxyglucose (FDG) PET‐CT scan food global pandemic help identify incidence injection ipsilateral janssen knowledge Lymph node Lymphadenopathy malignancies management Metastasis Moderna oncologist pathologic Patient patients Pfizer presenting Prevent radiologist reactive reported risk shown Side effect systematic literature search systematic review the vaccine tomography Transmission vaccination Vaccine was performed
[DOI] 10.1002/jmv.27599 PMC 바로가기 [Article Type] Review

Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis

Cardiovascular Medicine

Published on 2022-01-242022-10-31
Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19,

GM-CSF: Orchestrating the Pulmonary Response to Infection

Pharmacology

Published on 2022-01-172022-10-31
Journal: Frontiers in Pharmacology [Category] COVID-19,

Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2

SARS-CoV-2가 확인된 3명의 환자로부터 한 쌍의 경기관지 생검 표본 및 폐 부검 샘플에서 사후 조직병리학적 및 미세구조적 소견 비교

Article

Published on 2022-01-062022-09-11
Journal: American journal of clinical pathology [Category] SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus alveolar alveolar damage Antemortem ARDS Autopsies Autopsy biopsy cause of death Chain Reaction change clinical evaluation Computed tomography Confirmed coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19-induced lung injury DAD death detectable died different time point different time points diffuse Diffuse alveolar damage disease enrolled fibrosis finding Fluorescence High-resolution histology Hospital admission In situ hybridization latency lung Lung fibrosis Lung injury Lung pathology one patient Organizing pneumonia pathologic Patient patients with COVID-19 performed pneumocyte Pneumonia polymerase chain polymerase chain reaction Postmortem progression reactive respiratory Respiratory failure reverse transcription reverse transcription polymerase chain reaction Sample SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specimen Spread TBB the disease the patient tissue sample transbronchial upper airway upper airways Vascular Viral Viral load virus widespread
[DOI] 10.1093/ajcp/aqab087 PMC 바로가기 [Article Type] Article

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

비인간 영장류에서 COVID-19에 대한 재조합 식물 유래 바이러스 유사 입자 백신 후보의 비보조제 및 애주번트 제형이 제공하는 안전성, 면역원성 및 보호

Article

Published on 2022-01-052022-09-12
Journal: Cellular and Molecular Immunology [Category] COVID19(2023년), MERS, SARS, 비임상, 임상, 진단, 치료기술, 치료법,

[키워드] acute respiratory syndrome adjuvant adjuvants administration animal Antiviral AS03 BALF booster Bronchoalveolar lavage fluid CD4 T cells Cell-mediated immune responses chemotactic factor clinical trials coronavirus coronavirus disease COVID-19 CoVLP CoVLP vaccine CpG CpG1018 demonstrated dose effective vaccine Efficacy Evidence expression humoral IL-4 Immune cell immunization immunized Infection Influenza Intramuscular injection intranasal Lower lung nasal swab Non-humane primates ocular pandemic pathologic plaque-forming unit priming Proinflammatory cytokine Protein vaccines provided reduced responses rhesus macaque Safety SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2-infected cell selected significantly single dose stimulated System vaccine candidate Vaccine development vaccine-associated enhanced disease viral replication virus-like particle vaccine virus-like particles VLP
[DOI] 10.1038/s41423-021-00809-2 PMC 바로가기 [Article Type] Article

Impact of COVID-19 on presentation, staging, and treatment of head and neck mucosal squamous cell carcinoma

Research article

Published on 2022-01-012022-10-05
Journal: American journal of otolaryngology [Category] SARS, 치료법,

Human alveolar type 2 epithelium transdifferentiates into metaplastic KRT5+ basal cells

Research

Published on 2021-12-302022-10-05
Journal: Nature cell biology [Category] 바이오마커, 유전자 메커니즘,

Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection

SARS-CoV-2 감염에서 뉴로필린 1을 표적으로 하는 관점 및 잠재적 접근

Review

Published on 2021-12-272022-09-10
Journal: Molecular Medicine [Category] SARS, 치료제,

[키워드] ACE2, angiotensin converting enzyme 2 acute respiratory syndrome acute respiratory syndrome coronavirus approach CendR C-end rule Comorbidities conditions coronavirus COVID-19 pandemic COVID-19, Coronavirus disease 2019 dead Host immune response immunological Immunotargets and strategies Infection Interaction mechanism Molecular structures NRP-1, neuropilin-1 NRP1 pathologic Perspective Protein RBD, receptor-biding domain receptor respiratory responsible SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe disease manifestations spike Spike protein to define virus virus entry virus infectivity
[DOI] 10.1186/s10020-021-00423-y PMC 바로가기 [Article Type] Review

Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2 -transgenic mice

비활성화된 SARS-CoV-2는 인간 ACE2 형질전환 마우스에서 급성 호흡곤란 증후군을 유발합니다

Article

Published on 2021-12-242022-09-10
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 유전자 메커니즘, 치료제,

[키워드] ACE2 Activated neutrophils Activation acute respiratory distress acute respiratory distress syndrome Adaptive immune response alveolar damage animal model animal models ARDS Biological models biosafety biosafety level captures change changes in Characteristics characterized consolidation COVID-19 cytokine Cytokines detrimental develop Dexamethasone Diffuse alveolar damage Disease progression formaldehyde generate hACE2 hemorrhage human ACE2 humans hyaline membrane hyaline membrane formation IL-1β IL-6 induce Infection Infectious diseases infiltration Inflammation Inflammatory inflammatory monocyte Laboratory limit live SARS-CoV-2 lung macrophages mice monocyte-macrophages mouse model necrotic necrotic debris Neutrophils open passive antibody therapy pathologic pathological mechanism progression reported Research researcher respiratory distress Respiratory distress syndrome resulting robust SARS-CoV-2 syndrome T cell T cells the disease Therapeutic strategies therapeutic strategy TNF-α utilization weight loss
[DOI] 10.1038/s41392-021-00851-6 PMC 바로가기 [Article Type] Article